Synthesis and surface modification of magnetic nanoparticles for potential applications in sarcomas
Source abstract
Abstract
The application of nano-science in cancer therapy has become one of the most attractive tools in scientific research because of its versatility in diagnosis and treatment. Among the different types of nanoparticles, iron oxide nanoparticles (IONPs) are renowned for their low toxicity and suitability for therapeutic and diagnostic, or ‘theragnostic,’ approach against different types of cancers. Research investigating the effect of IONPs with different physiochemical characteristics in sarcoma is limited. In this study, we initially prepared IONPs of different sizes (200, 100, 20, and 10 nm) and modified their surface with different types of coatings (polyethylene glycol, d-glucose, and silica) under mild conditions. Various methods were used to illustrate and quantify cellular uptake of magnetic nanoparticles in sarcoma cell lines. Finally, the safety of the uptaken nanoparticles on diverse human sarcoma cell lines was investigated and found that the readily available IONPs can be taken up by synovial sarcoma and liposarcoma cell lines in the selective histological tumor types; however, they seem highly toxic for fibrous histiocytoma and fibrosarcoma.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Sarcoma Diagnosis and Treatment · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (98)
Show source-provided references
1. Ahmad MB, Tay MY, Shameli K, Hussein MZ, Lim JJ (2011) Green synthesis and characterization of silver/chitosan/polyethylene glycol nanocomposites without any reducing agent. Int J Mol Sci. doi: 10.3390/ijms12084872
2. Ankamwar B, Lai TC, Huang JH, Liu RS, Hsiao M, Chen CH, Hwu YK (2010) Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology. doi: 10.1088/0957-4484/21/7/075102
3. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA (2005) A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed. doi: 10.1002/nbm.970
4. Ayala V, Herrera A, Latorre-Esteves M, Torres-Lugo M, Rinaldi C (2013) Effect of surface charge on the colloidal stability and in vitro uptake of carboxymethyl dextran-coated iron oxide nanoparticles. J Nanopart Res. doi: 10.1007/s11051-013-1874-0
5. Babincova M, Altanerova V, Altaner C, Bergemann C, Babinec P (2008) In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Trans Nanobiosci. doi: 10.1109/TNB.2008.2000145
6. Babincová M, Altanerová V, Altaner Č, Čičmanec P, Babinec P (2004) In vivo heating of magnetic nanoparticles in alternating magnetic field. Med Phys. doi: 10.1118/1.1767101
7. Berry CC, Wells S, Charles S, Curtis ASG (2003) Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials. doi: 10.1016/S0142-9612(03)00237-0
8. Boyer C, Whittaker MR, Bulmus V, Liu J, Davis TP (2010) The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications. NPG Asia Mater. doi: 10.1038/asiamat.2010.6
9. Butoescu N, Seemayer CA, Palmer G, Guerne P-A, Gabay C, Doelker E, Jordan O (2009) Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice. Arthritis Res Ther. doi: 10.1186/ar2701
10. Castillo B, Bromberg L, López X, Badillo V, González Feliciano JA, González CI, Hatton TA, Barletta G (2012) Intracellular delivery of siRNA by polycationic superparamagnetic nanoparticles. J Drug Deliv. doi: 10.1155/2012/21894010.1155/2012/218940 ↗
11. Chen C, Jiang X, Kaneti YV, Yu A (2013) Design and construction of polymerized-glucose coated Fe3O4 magnetic nanoparticles for delivery of aspirin. Powder Technol. doi: 10.1016/j.powtec.2012.03.008
12. Chen F, Yan F, Chen Q, Wang Y, Han L, Chen Z, Fang S (2014) Fabrication of Fe3O4@SiO2@TiO2 nanoparticles supported by graphene oxide sheets for the repeated adsorption and photocatalytic degradation of rhodamine B under UV irradiation. Dalton Trans. doi: 10.1039/C4DT01702A
13. Cochran DB, Wattamwar PP, Wydra R, Hilt JZ, Anderson KW, Eitel RE, Dziubla TD (2013) Suppressing iron oxide nanoparticle toxicity by vascular targeted antioxidant polymer nanoparticles. Biomaterials. doi: 10.1016/j.biomaterials.2013.08.025
14. Crichton RR, Charloteaux-Wauters M (1987) Iron transport and storage. Eur J Biochem. doi: 10.1111/j.1432-1033.1987.tb11155.x
15. Curcio A, Marotta R, Riedinger A, Palumberi D, Falqui A, Pellegrino T (2012) Magnetic pH-responsive nanogels as multifunctional delivery tools for small interfering RNA (siRNA) molecules and iron oxide nanoparticles (IONPs). Chem Commun. doi: 10.1039/C2CC17223B
16. Fan C, Gao W, Chen Z, Fan H, Li M, Deng F, Chen Z (2011) Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles. Int J Pharm. doi: 10.1016/j.ijpharm.2010.10.038
17. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T (2003) In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials. doi: 10.1016/S0142-9612(02)00445-3
18. Freeman MW, Arrott A, Watson JHL (1960) Magnetism in medicine. J Appl Phys. doi: 10.1063/1.1984765
19. Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY (1983) Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 36:539–54510.1136/jcp.36.5.539 ↗
20. Ge J, Hu Y, Biasini M, Beyermann WP, Yin Y (2007) Superparamagnetic magnetite colloidal nanocrystal clusters. Angew Chem Int Ed Engl. doi: 10.1002/anie.200700197
21. Guo Z, Zhang D, Wei S, Wang Z, Karki A, Li Y, Bernazzani P, Young DP, Gomes JA, Cocke D, Ho T (2010) Effects of iron oxide nanoparticles on polyvinyl alcohol: interfacial layer and bulk nanocomposites thin film. J Nanopart Res. doi: 10.1007/s11051-009-9802-z
22. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. doi: 10.1016/j.biomaterials.2004.10.012
23. Hao Q, Liu S, Yin X, Du Z, Zhang M, Li L, Wang Y, Wang T, Li Q (2011) Flexible morphology-controlled synthesis of mesoporous hierarchical α-Fe2O3 architectures and their gas-sensing properties. CrystEngComm. doi: 10.1039/C0CE00194E
24. Harifi T, Montazer M (2014) In situ synthesis of iron oxide nanoparticles on polyester fabric utilizing color, magnetic, antibacterial and sono-Fenton catalytic properties. J Mater Chem B. doi: 10.1039/C3TB21445A
25. Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. doi: 10.1038/nrd1033
26. Hayashi K, Ono K, Suzuki H, Sawada M, Moriya M, Sakamoto W, Yogo T (2010) High-frequency, magnetic-field-Responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect. ACS Appl Mater Interfaces. doi: 10.1021/am100237p
27. Heslin M, Lewis J, Woodruff J, Brennan M (1997) Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol. doi: 10.1007/BF02305557
28. Hineno M (1977) Infrared spectra and normal vibration of β-d-glucopyranose. Carbohydr Res. doi: 10.1016/S0008-6215(00)83344-3
29. Hogemann-Savellano D, Bos E, Blondet C, Sato F, Abe T, Josephson L, Weissleder R, Gaudet J, Sgroi D, Peters PJ, Basilion JP (2003) The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia. doi: 10.1016/S1476-5586(03)80034-9
30. Hou Z, Han J, Zhan C, Zhou C, Hu Q, Zhang Q (2010) Synthesis and evaluation of N-succinyl-chitosan nanoparticles toward local hydroxycamptothecin delivery. Carbohydr Polym. doi: 10.1016/j.carbpol.2010.02.009
31. Hua MY, Yang HW, Liu HL, Tsai RY, Pang ST, Chuang KL, Chang YS, Hwang TL, Chang YH, Chuang HC, Chuang CK (2011) Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy. Biomaterials. doi: 10.1016/j.biomaterials.2011.08.014
32. Huang IP, Sun SP, Cheng SH, Lee CH, Wu CY, Yang CS, Lo LW, Lai YK (2011a) Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance. Mol Cancer Ther. doi: 10.1158/1535-7163.mct-10-0884
33. Huang X, Li L, Liu T, Hao N, Liu H, Chen D, Tang F (2011b) The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano. doi: 10.1021/nn200365a
34. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. doi: 10.1016/j.tiv.2005.06.034
35. Islam T, Josephson L (2009) Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles. Cancer Biomark. doi: 10.3233/cbm-2009-0615
36. Jarzyna PA, Skajaa T, Gianella A, Cormode DP, Samber DD, Dickson SD, Chen W, Griffioen AW, Fayad ZA, Mulder WJM (2009) Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging. Biomaterials. doi: 10.1016/j.biomaterials.2009.09.004
37. Kadiiska MB, Burkitt MJ, Xiang QH, Mason RP (1995) Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation. J Clin Investig. doi: 10.1172/jci118205
38. Karlsson HL, Cronholm P, Gustafsson J, Möller L (2008) Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol. doi: 10.1021/tx800064j
39. Karlsson HL, Gustafsson J, Cronholm P, Möller L (2009) Size-dependent toxicity of metal oxide particles—a comparison between nano- and micrometer size. Toxicol Lett. doi: 10.1016/j.toxlet.2009.03.014
40. Kim JS, Yoon T-J, Yu KN, Kim BG, Park SJ, Kim HW, Lee KH, Park SB, Lee J-K, Cho MH (2006) Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci. doi: 10.1093/toxsci/kfj027
41. Krukemeyer MG, Krenn V, Jakobs M, Wagner W (2012a) Mitoxantrone–iron oxide biodistribution in blood, tumor, spleen, and liver—magnetic nanoparticles in cancer treatment. J Surg Res. doi: 10.1016/j.jss.2011.01.060
42. Krukemeyer MG, Krenn V, Jakobs M, Wagner W (2012b) Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite–dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets—sarcoma treatment in progress. J Drug Target. doi: 10.3109/1061186X.2011.622399
43. Kuhn S, Hallahan D, Giorgio T (2006) Characterization of superparamagnetic nanoparticle interactions with extracellular matrix in an in vitro system. Ann Biomed Eng. doi: 10.1007/s10439-005-9004-5
44. Kyoungja W, Hong J (2005) Surface modification of hydrophobic iron oxide nanoparticles for clinical applications. IEEE Trans Magn. doi: 10.1109/TMAG.2005.855343
45. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. doi: 10.1021/cr068445e
46. Lesniak A, Salvati A, Santos-Martinez MJ, Radomski MW, Dawson KA, Åberg C (2013) Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc. doi: 10.1021/ja309812z
47. Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nanoparticles. Small. doi: 10.1002/smll.200700595
48. Li Z, Wei L, Gao MY, Lei H (2005) One-pot reaction to synthesize biocompatible magnetite nanoparticles. Adv Mater. doi: 10.1002/adma.200401545
49. Li Q, Tang G, Xue S, He X, Miao P, Li Y, Wang J, Xiong L, Wang Y, Zhang C, Yang G-Y (2013a) Silica-coated superparamagnetic iron oxide nanoparticles targeting of EPCs in ischemic brain injury. Biomaterials. doi: 10.1016/j.biomaterials.2013.03.030
50. Li L, Jiang W, Luo K, Song H, Lan F, Wu Y, Gu Z (2013b) Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics. doi: 10.7150/thno.5366
51. Li W-P, Liao P-Y, Su C-H, Yeh C-S (2014) Formation of oligonucleotide-gated silica shell-coated Fe3O4–Au core–shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform. J Am Chem Soc. doi: 10.1021/ja504118q
52. Lien Y-H, Wu T-M, Wu J-H, Liao J-W (2011) Cytotoxicity and drug release behavior of PNIPAM grafted on silica-coated iron oxide nanoparticles. J Nanopart Res. doi: 10.1007/s11051-011-0487-8
53. Liu Q, Zhang J, Sun W, Xie QR, Xia W, Gu H (2012) Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. Int J Nanomed. doi: 10.2147/ijn.s28088
54. Lu C, Bhatt LR, Jun HY, Park SH, Chai KY (2012) Carboxyl-polyethylene glycol–phosphoric acid: a ligand for highly stabilized iron oxide nanoparticles. J Mater Chem. doi: 10.1039/C2JM34327D
55. Maeng JH, Lee DH, Jung KH, Bae YH, Park IS, Jeong S, Jeon YS, Shim CK, Kim W, Kim J, Lee J, Lee YM, Kim JH, Kim WH, Hong SS (2010) Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials. doi: 10.1016/j.biomaterials.2010.02.068
56. Mahmoudi M, Simchi A, Milani AS, Stroeve P (2009) Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci. doi: 10.1016/j.jcis.2009.04.046
57. Mahmoudi M, Milani AS, Stroeve P (2010) Synthesis, surface architecture and biological response of superparamagnetic iron oxide nanoparticles for application in drug delivery: a review. Int J Biomed Nanosci Nanotechnol. doi: 10.1504/IJBNN.2010.034651
58. Max J-J, Chapados C (2007) Glucose and fructose hydrates in aqueous solution by IR spectroscopy. J Phys Chem A. doi: 10.1021/jp066882r
59. Mingwu S, Hongdong C, Xifu W, Xueyan C, Kangan L, Su He W, Rui G, Linfeng Z, Guixiang Z, Xiangyang S (2012) Facile one-pot preparation, surface functionalization, and toxicity assay of APTS-coated iron oxide nanoparticles. Nanotechnology. doi: 10.1088/0957-4484/23/10/105601
60. Mohapatra S, Mallick SK, Maiti TK, Ghosh SK, Pramanik P (2007) Synthesis of highly stable folic acid conjugated magnetite nanoparticles for targeting cancer cells. Nanotechnology. doi: 10.1088/0957-4484/18/38/385102
61. Moore A, Basilion JP, Chiocca EA, Weissleder R (1998) Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta Mol Cell Res. doi: 10.1016/S0167-4889(98)00002-0
62. Munnier E, Cohen-Jonathan S, Hervé K, Linassier C, Soucé M, Dubois P, Chourpa I (2011) Doxorubicin delivered to MCF-7 cancer cells by superparamagnetic iron oxide nanoparticles: effects on subcellular distribution and cytotoxicity. J Nanopart Res. doi: 10.1007/s11051-010-0093-1
63. Nakase M, Inui M, Okumura K, Kamei T, Nakamura S, Tagawa T (2005) p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome. Mol Cancer Ther. doi: 10.1158/1535-7163.mct-04-0196
64. Neoh KG, Kang ET (2011) Functionalization of inorganic nanoparticles with polymers for stealth biomedical applications. Polym Chem. doi: 10.1039/C0PY00266F
65. Ortega R, Giorgio T (2012) A mathematical model of superparamagnetic iron oxide nanoparticle magnetic behavior to guide the design of novel nanomaterials. J Nanopart Res. doi: 10.1007/s11051-012-1282-x
66. Petri Fink A, Chastellain M, Juillerat Jeanneret L, Ferrari A, Hofmann H (2005) Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials. doi: 10.1016/j.biomaterials.2004.07.023
67. Rahman IA, Padavettan V (2012) Synthesis of silica nanoparticles by sol–gel: size-dependent properties, surface modification, and applications in silica–polymer nanocomposites—a review. J Nanomater. doi: 10.1155/2012/132424
68. Recht L, Torres CO, Smith TW, Raso V, Griffin TW (1990) Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg. doi: 10.3171/jns.1990.72.6.0941
69. Rosen JE, Chan L, Shieh D-B, Gu FX (2012) Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine. doi: 10.1016/j.nano.2011.08.017
70. Schulze E, Ferrucci JTJ, Poss K, Lapointe L, Bogdanova A, Weissleder R (1995) Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Investig Radiol 30:604–61010.1097/00004424-199510000-00006 ↗
71. Sharma RK, Monga Y, Puri A, Gaba G (2013) Magnetite (Fe3O4) silica based organic–inorganic hybrid copper(II) nanocatalyst: a platform for aerobic N-alkylation of amines. Green Chem. doi: 10.1039/C3GC40818C
72. Shultz MD, Calvin S, Fatouros PP, Morrison SA, Carpenter EE (2007) Enhanced ferrite nanoparticles as MRI contrast agents. J Magn Magn Mater. doi: 10.1016/j.jmmm.2006.10.1188
73. Singh N, Jenkins GJS, Asadi R, Doak SH (2010) Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. doi: 10.3402/nano.v1i0.5358
74. Singh R, Misra V, Singh R (2011) Synthesis, characterization and role of zero-valent iron nanoparticle in removal of hexavalent chromium from chromium-spiked soil. J Nanopart Res. doi: 10.1007/s11051-011-0350-y
75. Socrates G (2004) Infrared and Raman characteristic group frequencies: tables and charts. Wiley, Chichester
76. Soenen SJH, Baert J, De Cuyper M (2007) Optimal conditions for labelling of 3T3 fibroblasts with magnetoliposomes without affecting cellular viability. ChemBioChem. doi: 10.1002/cbic.200700327
77. Soenen SJH, Himmelreich U, Nuytten N, De Cuyper M (2011) Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials. doi: 10.1016/j.biomaterials.2010.08.075
78. Song H-J, Jia X-H, Qi H, Yang X-F, Tang H, Min C-Y (2012) Flexible morphology-controlled synthesis of monodisperse [small alpha]-Fe2O3 hierarchical hollow microspheres and their gas-sensing properties. J Mater Chem. doi: 10.1039/C2JM13574D
79. Sterenczak KA, Meier M, Glage S, Meyer M, Willenbrock S, Wefstaedt P, Dorsch M, Bullerdiek J, Murua Escobar H, Hedrich H, Nolte I (2012) Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer. BMC Cancer. doi: 10.1186/1471-2407-12-284
80. Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, Wang SX, Li G (2003) Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc. doi: 10.1021/ja0380852
81. Sun C, Veiseh O, Gunn J, Fang C, Hansen S, Lee D, Sze R, Ellenbogen RG, Olson J, Zhang M (2008) In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small. doi: 10.1002/smll.200700784
82. Thomas R, Park IK, Jeong Y (2013) Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer. Int J Mol Sci. doi: 10.3390/ijms140815910
83. Thorek DJ, Chen A, Czupryna J, Tsourkas A (2006) Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng. doi: 10.1007/s10439-005-9002-7
84. Tsoufis Τ, Douvalis A, Lekka C, Trikalitis P, Bakas T, Gournis D (2013) Controlled preparation of carbon nanotube–iron oxide nanoparticle hybrid materials by a modified wet impregnation method. J Nanopart Res. doi: 10.1007/s11051-013-1924-7
85. Wahajuddin SA (2012) Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomed. doi: 10.2147/IJN.S30320
86. Widder KJ, Senyei AE (1983) Magnetic microspheres: a vehicle for selective targeting of drugs. Pharmacol Ther. doi: 10.1016/0163-7258(83)90033-5
87. Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AE (1983a) Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. Eur J Cancer Clin Oncol. doi: 10.1016/0277-5379(83)90408-X
88. Widder KJ, Marino PA, Morris RM, Howard DP, Poore GA, Senyei AE (1983b) Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition. Eur J Cancer Clin Oncol. doi: 10.1016/0277-5379(83)90409-1
89. Wilson MR, Lightbody JH, Donaldson K, Sales J, Stone V (2002) Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol Appl Pharmacol. doi: 10.1006/taap.2002.9501
90. Wu W, He Q, Jiang C (2008) Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res Lett. doi: 10.1007/s11671-008-9174-9
91. Xuan S, Wang Y-XJ, Yu JC, Cham-Fai Leung K (2009) Tuning the grain size and particle size of superparamagnetic Fe3O4 microparticles. Chem Mater. doi: 10.1021/cm901618m
92. Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S (2011) Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials. doi: 10.1016/j.biomaterials.2011.03.018
93. Yang H-M, Park CW, Bae PK, Ahn T, Seo B-K, Chung BH, Kim J-D (2013) Folate-conjugated cross-linked magnetic nanoparticles as potential magnetic resonance probes for in vivo cancer imaging. J Mater Chem B. doi: 10.1039/C3TB20295J
94. Yu M, Howe J, Jeong K, Shim I, Kim W, Kim C, Ahn J, Lee J, Urban MW (2010) Structural and morphological features of concentric iron oxide/carbon nanotubes obtained from phospholipids. J Mater Chem. doi: 10.1039/C0JM00753F
95. Zhang G, Liao Y, Baker I (2010) Surface engineering of core/shell iron/iron oxide nanoparticles from microemulsions for hyperthermia. Mater Sci Eng C. doi: 10.1016/j.msec.2009.09.003
96. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM (2001) Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med. doi: 10.1038/nm1101-1241
97. Zheng J, Liu ZQ, Zhao XS, Liu M, Liu X, Chu W (2012) One-step solvothermal synthesis of Fe3O4 @C core–shell nanoparticles with tunable sizes. Nanotechnology. doi: 10.1088/0957-4484/23/16/165601
98. Zhu MT, Wang B, Wang Y, Yuan L, Wang HJ, Wang M, Ouyang H, Chai ZF, Feng WY, Zhao YL (2011) Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol Lett. doi: 10.1016/j.toxlet.2011.03.021